933770-71-9

Basic information

• Product Name: α-benzyloxymethyl-γ-lactone
• CAS NO: 933770-71-9
• Molecular Weight: 206.241
• Mol File: 933770-71-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: α-benzyloxymethyl-γ-lactone(CAS DataBase Reference)
• NIST Chemistry Reference: α-benzyloxymethyl-γ-lactone(933770-71-9)
• EPA Substance Registry System: α-benzyloxymethyl-γ-lactone(933770-71-9)

Safety Data

• Hazardous Substances Data: 933770-71-9(Hazardous Substances Data)

Usage

General Description

α-benzyloxymethyl-γ-lactone is a chemical compound with a benzyl group attached to a lactone ring. It is commonly used in organic synthesis as a protecting group for alcohols, allowing for selective reactions to occur without interference from other functional groups. The benzyl group can be easily removed under mild conditions, making it a versatile tool for the modification of complex molecules. α-benzyloxymethyl-γ-lactone has also been studied for its potential therapeutic applications, such as anti-inflammatory and antitumor properties. Overall, this compound plays a crucial role in the field of medicinal chemistry and drug discovery.

Upstream product

• 100460-14-8 (+/-)-cis,trans-(2-methoxytetrahydrofuran-3-yl)methanol 
• 89941-77-5 2-methoxy-tetrahydro-furan-3-carboxylic acid methyl ester 
• 127915-15-5 2-oxotetrahydrofuran-3-carboxylic acid methyl ester 
• 191347-98-5 (R)-2,2-dimethyl-1,3-dioxepane-5-carbaldehyde 
• 191348-00-2 2-methoxytetrahydrofuran-(3R)-ylmethanol 
• 100-39-0 benzyl bromide 
• 191348-01-3 (R)-3-Benzyloxymethyl-2-methoxy-tetrahydro-furan 
• 88481-68-9 (R)-2-((benzyloxy)methyl)pent-4-en-1-ol 
• 143426-36-2 (S)-methyl 2-((benzyloxy)methyl)pent-4-enoate 
• 143426-35-1 (S)-2-((benzyloxy)methyl)pent-4-enoic acid 

Downstream Products

• 1350436-99-5 C₁₈H₁₆ClFN₄O₃ 
• 1350437-00-1 C₁₈H₁₆ClFN₄O₃ 

Relevant articles and documents

HETEROCYCLIC AMIDES AS ROCK INHIBITORS

The present invention relates to new kinase inhibitors of formula (I), more specifically ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In particular, the present invention relates to new ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In addition, the invention relates to methods of treatment and use of said compounds in the manufacture of a medicament for the application to a number of therapeutic indications including sexual dysfunction, inflammatory diseases, ophthalmic diseases and Respiratory diseases.

Studies of ring-closing mode of 4-hydroxy-2-vinylidenebutanoates: 5-exo-trig versus 5-endo-dig

The ring-closing mode of benzyl 4-hydroxy-2-vinylidenebutanoates (5-exo-trig vs 5-endo-dig) could precisely be controlled in a highly selective manner by the proper choice of conditions (solvent and base).

Chemoenzymatic Approach to the Synthesis of the Antiviral Agents Penciclovir and Famciclovir in Isotopically Chiral Labelled Form

The antiviral agents penciclovir and famciclovir have been synthesised in isotopically chiral form.The synthesis of (+)-methyl 4-benzyloxy-2-(hydroxymethyl)butanoate 12a by use of enzymatic hydrolysis catalysed by the lipase from Candida cylindrac